{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:35:26Z","timestamp":1774262126055,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T00:00:00Z","timestamp":1361404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/hr.2013.10","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T07:11:49Z","timestamp":1361430709000},"page":"620-626","source":"Crossref","is-referenced-by-count":16,"title":["Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study"],"prefix":"10.1038","volume":"36","author":[{"given":"Mitsuru","family":"Ohishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Katsuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kamide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,21]]},"reference":[{"key":"BFhr201310_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/08037050701461084","volume":"16","author":"G Mansia","year":"2007","unstructured":"Mansia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, European Society of Hypertension; European Society of Cardiology. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007; 16: 135\u2013232.","journal-title":"Blood Press"},{"key":"BFhr201310_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ . Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206\u20131252.","journal-title":"Hypertension"},{"key":"BFhr201310_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2165\/00003495-200161100-00009","volume":"61","author":"M Sharpe","year":"2001","unstructured":"Sharpe M, Jarvis B, Goa KL . Telmisartan: a review of its use in hypertension. Drugs 2001; 61: 1501\u20131529.","journal-title":"Drugs"},{"key":"BFhr201310_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1524-6175.2003.01612.x","volume":"1","author":"JM Neutel","year":"2003","unstructured":"Neutel JM, Smith DHG . Evaluation of angiotensin II receptor blockers for 24-hour blood pressure control: meta-analysis of a clinical database. J Clin Hypertens 2003; 1: 58\u201363.","journal-title":"J Clin Hypertens"},{"key":"BFhr201310_CR5","first-page":"31","volume":"6","author":"F Kontny","year":"2010","unstructured":"Kontny F, Risanger T, Bye A, Arnesen \u00d8, Johansen OE, TELMIMORE Study Investigators. Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care. Vasc Health Risk Manag 2010; 6: 31\u201338.","journal-title":"Vasc Health Risk Manag"},{"key":"BFhr201310_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2165\/00003495-199550030-00009","volume":"50","author":"M Haria","year":"1995","unstructured":"Haria M, Wagstaff AJ . Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. Drugs 1995; 50: 560\u2013586.","journal-title":"Drugs"},{"key":"BFhr201310_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahl\u00f6f","year":"2005","unstructured":"Dahl\u00f6f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895\u2013906.","journal-title":"Lancet"},{"key":"BFhr201310_CR8","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahl\u00f6f B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ, ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417\u20132428.","journal-title":"N Engl J Med"},{"key":"BFhr201310_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","volume":"120","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Kamalakkannan G, Parkar S, Messerli FH . Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120: 713\u2013719.","journal-title":"Am J Med"},{"key":"BFhr201310_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","volume":"55","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Arshad S, Poulter NR . Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55: 399\u2013407.","journal-title":"Hypertension"},{"key":"BFhr201310_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1751-7176.2011.00468.x","volume":"13","author":"S Neldam","year":"2011","unstructured":"Neldam S, Lang M, Jones R, TEAMSTA-5 Investigators. Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study. J Clin Hypertens 2011; 13: 459\u2013466.","journal-title":"J Clin Hypertens"},{"key":"BFhr201310_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.107.094235","volume":"50","author":"RC Hermida","year":"2007","unstructured":"Hermida RC, Ayala DE, Fern\u00e1ndez JR, Calvo C . Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 2007; 50: 715\u2013722.","journal-title":"Hypertension"},{"key":"BFhr201310_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/01.hjh.0000163132.84890.c4","volume":"23","author":"E O'Brien","year":"2005","unstructured":"O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P, European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23: 697\u2013701.","journal-title":"J Hypertens"},{"key":"BFhr201310_CR14","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982\u2013992.","journal-title":"Am J Kidney Dis"},{"key":"BFhr201310_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.E580","volume":"15","author":"T Teramoto","year":"2008","unstructured":"Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M . Metabolic syndrome. J Atheroscler Thromb. 2008; 15: 1\u20135.","journal-title":"J Atheroscler Thromb."},{"key":"BFhr201310_CR16","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/00004872-199312000-00013","volume":"11","author":"T Mengden","year":"1993","unstructured":"Mengden T, Binswanger B, Sp\u00fchler T, Weisser B, Vetter W . The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993; 11: 1403\u20131411.","journal-title":"J Hypertens"},{"key":"BFhr201310_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2146\/ajhp060663","volume":"65","author":"K Chavanu","year":"2008","unstructured":"Chavanu K, Merkel J, Quan AM . Role of ambulatory blood pressure monitoring in the management of hypertension. Am J Health Syst Pharm 2008; 65: 209\u2013218.","journal-title":"Am J Health Syst Pharm"},{"key":"BFhr201310_CR18","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa022273","volume":"348","author":"DL Clement","year":"2003","unstructured":"Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E, Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407\u20132415.","journal-title":"N Engl J Med"},{"key":"BFhr201310_CR19","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903\u20131913.","journal-title":"Lancet"},{"key":"BFhr201310_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","volume":"46","author":"E Dolan","year":"2005","unstructured":"Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O\u2019Brien E . Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46: 156\u2013161.","journal-title":"Hypertension"},{"key":"BFhr201310_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/HJH.0b013e328350bb40","volume":"30","author":"A de la Sierra","year":"2012","unstructured":"de la Sierra A, Banegas JR, Segura J, Gorostidi M, Ruilope LM, CARDIORISC Event Investigators. Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study. J Hypertens 2012; 30: 713\u2013719.","journal-title":"J Hypertens"},{"key":"BFhr201310_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/08037051.2011.587280","volume":"20","author":"C Cuspidi","year":"2011","unstructured":"Cuspidi C, Sala C, Valerio C, Negri F, Mancia G . Nocturnal blood pressure in untreated essential hypertensives. Blood Press 2011; 20: 335\u2013341.","journal-title":"Blood Press"},{"key":"BFhr201310_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MBP.0b013e3283360ed1","volume":"15","author":"SD Pierdomenico","year":"2010","unstructured":"Pierdomenico SD, Cuccurullo F . Ambulatory blood pressure monitoring in type 2 diabetes and metabolic syndrome: a review. Blood Press Monit 2010; 15: 1\u20137.","journal-title":"Blood Press Monit"},{"key":"BFhr201310_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2165\/00003495-200666010-00004","volume":"66","author":"AJ Battershill","year":"2006","unstructured":"Battershill AJ, Scott LJ . Telmisartan: a review of its use in the management of hypertension. Drugs 2006; 66: 51\u201383.","journal-title":"Drugs"},{"key":"BFhr201310_CR25","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1517\/14656566.9.8.1397","volume":"9","author":"T Inoue","year":"2008","unstructured":"Inoue T, Node K . Telmisartan as a metabolic sartan for targeting vascular failure. Expert Opin Pharmacother 2008; 9: 1397\u20131406.","journal-title":"Expert Opin Pharmacother"},{"key":"BFhr201310_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/HJH.0b013e3280104dba","volume":"25","author":"M Lindqvist","year":"2007","unstructured":"Lindqvist M, Kahan T, Melcher A, Ekholm M, Hjemdahl P . Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity. J Hypertens 2007; 25: 169\u2013175.","journal-title":"J Hypertens"},{"key":"BFhr201310_CR27","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/01.hjh.0000170389.69202.53","volume":"23","author":"M Karas","year":"2005","unstructured":"Karas M, Lacourci\u00e8re Y, LeBlanc AR, Nadeau R, Dub\u00e9 B, Florescu M, Lamarre-Cliche M, Poirier L, Larochelle P, de Champlain J . Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. J Hypertens 2005; 23: 1251\u20131260.","journal-title":"J Hypertens"},{"key":"BFhr201310_CR28","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM199606203342507","volume":"334","author":"TL Goodfriend","year":"1996","unstructured":"Goodfriend TL, Elliott ME, Catt KJ . Angiotensin receptors and their antagonists. N Engl J Med 1996; 334: 1649\u20131654.","journal-title":"N Engl J Med"},{"key":"BFhr201310_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.CIR.103.6.904","volume":"103","author":"M Burnier","year":"2001","unstructured":"Burnier M . Angiotensin II type 1 receptor blockers. Circulation 2001; 103: 904\u2013912.","journal-title":"Circulation"},{"key":"BFhr201310_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3317\/jraas.2004.017","volume":"5","author":"Y Uresin","year":"2004","unstructured":"Uresin Y, Erbas B, Ozek M, Ozk\u00f6k E, G\u00fcrol AO . Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress. J Renin Angiotensin Aldosterone Syst 2004; 5: 93\u201396.","journal-title":"J Renin Angiotensin Aldosterone Syst"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201310","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:12:01Z","timestamp":1684429921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,21]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFhr201310"],"URL":"https:\/\/doi.org\/10.1038\/hr.2013.10","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,21]]}}}